Intage Holdings Inc. TSE:4326

INTAGE : Explanation Materials for Consolidated Financial Results for the Six Months Ended December 31, 20252032KB

Published

Source: MarketScreener

‌Financial results presentation for institutional investors and analysts

Explanation Materials for Consolidated Financial Results for the Six Months Ended December 31, 2025

INTAGE HOLDINGS Inc.

Securities code: 4326

February 9, 2026



‌Sales saw a slight decrease. While panel research in the core businesses continued to grow steadily, the decline was due to factors such as the transfer of the CRO business in the previous fiscal year. Although the growth businesses expanded compared to the previous year, they fell short of the plan, resulting in performance below the initial forecast. Operating profit improved in profitability across all segments, finishing above both the previous year and the forecast. Profit attributable to owners of the parent decreased due to the absence of gains recorded from the CRO business transfer.

Consolidated Statement of Income

(Millions of yen)

6 months ended

Dec. 31, 2024

6 months ended

Dec. 31, 2025

Change from previous year

YoY

2Q Forecast

Net sales

32,027

31,688

338

1.1%

32,500

Operating expenses

30,245

29,324

921

△3.0

-

Operating profit

1,781

2,363

+582

+32.7%

2,000

Ordinary profit

1,744

2,381

+636

+36.5%

2,000

Profit attributable to owners of parent

2,017

1,220

797

△39.5

1,000

EPS (yen)

52.88

31.95

-

-

26.20

Summary of Consolidated Statements of Income

2



‌Operating profit increased significantly, benefitting from continued profit-oriented management initiatives and the elimination of the duplicate cost burden of SCI.

(Millions of yen)

1,781

345

186

-17

-339

2,363

407

2,500

2,000

1,500

1,000

500

0

Operating profit for 6 months ended December 31, 2024

Lower sales Variable costs Personnel

expenses

Costs Investment Operating profit for 6 months ended December 31, 2025

Net sales Personnel expenses

Investment

Sales decreased due to the transfer of the CRO business and the rebound effect from large-scale projects of INTAGE RESEARCH Inc. and Buildsystem Co.,Ltd in the previous fiscal year.



Increased due to salary revisions and other factors. But the overall level remained broadly in line with the previous fiscal year as a result of a decrease of employees by the transfer of the CRO business.

Decreased due to the completion of the transition to the new SCI.

Factors Contributing to Changes in Operating Profit

3



‌Other Overseas

Co

CR

Panel surveys

Net sales breakdown by product (Millions of yen)

24/12

25/12

Y/Y

Operating profit margin

Net sales

21,691

21,790

+0.5%

Operating profit

227

630

+177.5%

2.9%

(Millions of yen)

2,597

+8%

2,800

2,741

▲1%

2,720

1,810

▲18%

1,483

7,177

+0%

7,180

7,363

+3%

7,606

24/12

25/12

Other: Public-sector projects, RnI's CODE, etc.

Overseas: Sales from overseas subsidiaries (excluding healthcare)

Co: Communications area (i-SSP, Media Gauge, di-PiNK, etc.)

CR-Web: Internet surveys of custom research areas

Panel surveys: SRI+, SCI, etc.

Despite the reactionary impact from the large-scale projects recorded in the previous year at INTAGE RESEARCH Inc., the segment achieved revenue growth.

Panel surveys expanded, driven by price increases and the acquisition of new contracts.

In the advertising domain, service demand fluctuates in short cycles, leading to a decline in certain products in the Co category. Advertising-related services jointly promoted with NTT DOCOMO span multiple product categories, with steady progress in winning new projects.

In addition to increased revenue from highly profitable panel surveys, the completion of the transition to the new SCI enabled operating profit to significantly exceed the previous year's level.

Financial Results Highlights



  • From this fiscal year onward, "CR-WEB" and "CR (Other than WEB)" have been consolidated and disclosed as "CR."

  • From the second quarter, we reclassified a portion of panel survey items to "Other" to better reflect actual conditions.

©INTAGE GROUP

Performance by Segment: Marketing Support (Consumer Goods & Services)

4



‌Other Promotion

CRO

CR

Panel surveys

Net sales breakdown by product

307

313

1,382

328

0

2,735

2,715

2,126

1,874

+1%

1,299

▲6%

+13%

(Millions of yen)

24/12

25/12

Y/Y

Operating profit margin

Net sales

6,609

6,474

△2.0%

Operating profit

1,186

1,547

+30.4%

23.9%

(Millions of yen)

24/12

Due to the impact of the CRO business divestiture, revenue declined.

Panel research recorded significant year-on-year growth, supported by the acquisition of new contracts and price increases across product lines, with particularly strong contributions from the expansion of the prescription database provided by INTAGE Real World Inc.

While CR services continued to perform steadily, Promotion at Kyowa Kikaku Co., Ltd. fell below the previous year's level.

Although sales decreased, profitability improved, resulting in operating profit significantly exceeding that of the previous year.

Financial Results Highlights



25/12

Other: Healthcare sales of overseas subsidiaries, etc.

Promotion: Sales from promotion-related business conducted by KYOWA KIKAKU, Ltd.

CRO (Contract Research Organization)*: Post-marketing surveillance, etc.

CR: Custom research mainly for pharmaceutical companies and medical device manufacturers

Panel surveys: SRI+, Impact Track, prescription database, etc.

* As noted in the disclosure dated June 17, 2024, effective September 2, 2024 the CRO Business was transferred to Alfresa Holdings Corporation.

©INTAGE GROUP

Performance by Segment: Marketing Support (Healthcare)

5



‌DX

BPO

Net sales breakdown by area

952

966

1,506

1,235

896

1,596

▲6%

+8%

(Millions of yen)

24/12

25/12

Y/Y

Operating profit margin

Net sales

3,726

3,423

△8.1%

Operating profit

367

185

△49.5%

5.4%

SI

(Millions of yen)

24/12

▲23%

DX fell below the previous year due to a rebound effect from low-code development projects at Build System Inc., although the data integration and utilization business remained solid. SI also fell below the previous year due to a decline in projects from certain clients in the travel industry.

Operating profit declined due to lower sales, in addition to the one-time expenses associated with the consolidation and relocation of the Nagano office conducted in November 2025.

Financial Results Highlights



25/12

companies' sales information systems, publishing POS systems, trade area analyses, AI solutions.

Examples of solutions

INTAGE TECHNOSPHERE provides IT solutions. The company's business includes building and operating systems, and

managing data centers.

Payment systems for travel agencies, health management support services, pharmaceutical

INTAGE TECHNOSPHERE Inc. business lineup

DX: Support for promotion of DX-related areas in companies

BPO: BPO services such as business process efficiency improvement, system maintenance and management, etc.

SI: System development, etc.

Performance by Segment: Business Intelligence

6



‌Management Strategy Topics

‌14th Medium-Term Management Plan and the FY2025 Business Plan 8

14th Medium-Term Management Plan

Priority Issues

(FY2023-FY2025)

Basic Policy

Towards New Portfolio as a Data + Technology Company

- Creation of new value -

Group Strategy

Expanding business value with a goal of Toward 2030

Data Strategy

Promote a data strategy that increases the value of the company's data even as the market changes

Technology Strategy

Continue to take on the challenge of data utilization and DX support and cross industry boundaries

Co-creation Strategy

Promote group co-creation

to support the creation of new value

Basic Policy

FY2025 Business Plan

Priority Issues

Growth with Optimization

Establishment of a new business portfolio

1

Expanding business value with a goal of Toward 2030

2

Engage in business operations with a clear business portfolio (growth with optimization)

3

Shift to an optimal formation

to enhance overall group capabilities

©INTAGE GROUP



‌Shift toward business operations with clear core businesses and growth businesses



Develop new services and solutions and create synergies

with DOCOMO

Future possibilities

Large investments will allow for growth in new areas.

Key points

Sales

expansion

Generate projects in areas with growth potential

Emphasis on

results

Quick launch of new services.

Growth Businesses



Traditional marketing research such as panel surveys and

custom research

Future possibilities ▲

Sales continue to increase, but it is difficult to expect large growth.

Key points

Emphasis on

profit

Practice management focused on profit over sales

Offered value

Improved value to clients, price increases, etc.

Core Businesses



Leading the way to growth while maintaining balance

Shift from optimization of individual companies to a formation which enhance overall group capabilities.

Aim to create an organization that readily allows optimal allocation of business resources.

Allocate profits generated by core businesses to growth businesses that will lead to medium to long-term growth.

©INTAGE GROUP

Management Policy - Growth with Optimization -

9

For continued growth as a Data + Technology company with a goal ofToward 2030



‌EBPM - Initiatives to Expand the NTT Group's Urban Development Business - 10

SUGATAMI is provided as part of the SSPP (Sustainable Smart City Partner Program) promoted by the NTT Group to support municipal management and community development. Its purpose is to maximize regional and resident well-being and to visualize the attractiveness of the

community. By enabling an objective understanding and self-recognition of both the municipality's desired future state and its current conditions, the tool contributes to resident-centric municipal management and community development that leverages unique local characteristics, incorporating new value standards beyond economic measures (i.e., human-centered values).

Providing "SUGATAMI Reports": Urban data that reflects the current state of the city

  • NTT's unique set of 18 urban functionality domains

  • Levels of resident satisfaction with their city that could not be captured through conventional surveys

  • Analysis of residents' well-being together with satisfaction levels and urban functionality





Leveraging the strengths of the INTAGE Group to promote the commercialization of "SUGATAMI"

  • Starting in 2025, the Group will take the lead in operations related to SUGATAMI, a solution provided through the NTT Group's SSPP initiative.

  • Using report-related tasks-such as resident surveys, data collection and

    processing, and system-related support-as a foundation, the Group will move

    forward with:

    • exploring business models that leverage these reports,

    • conducting PoC initiatives in collaboration with municipalities,

    • and pursuing full-scale commercialization in the next phase.

      Interpreting SUGATAMI data:

      Supporting urban development through a broad and comprehensive scope

      • Detailed analysis of unique, city-specific data

      • Supporting planning efforts that help cities move toward their ideal future, based on an understanding of current conditions

      • Providing diverse support, including dispatching specialists and developing human resources



      Convenient and affluent society free from social loss

      Citizens, Government, Enterprises

Solving Social Issues Resident's Well-being Sustainable Economy

Transportation Logistics Consumption Economy Tourism Healthcare Education Urban Development

Governance

Action

Solution Solution Solution Solution Solution Solution Solution Solution

NTT Group

Suppor t

SUGATAMI Reports

※1 :EBPM(Evidence Based Policy Making)

※2 :SSPP(Sustainable Smart City Partner Program)https://digital-is-green.jp/

A project that supports the next generation of community development, aimed at maximizing the well-being of local communities and residents.It provides

a forum where members from industry, academia, government, and citizens can co-create sustainable and self-reliant frameworks, along with a wide range of solutions, technologies, and expertise that leverage the unique characteristics of each region.

©INTAGE GROUP



‌We have launched the first overseas consumer panel in Vietnam. We aim to establish this as a new growth driver in overseas business, which had primarily been custom research until now.



Overview of i-Panel

Update

Sales Update

Channel Coverage Main Categolies

    • Launched in October 2025

      Monitor

      Consumers in Vietnam (in five cities including Ho Chi Minh and Hanoi)

      Sample size

      6,000ss

      Data collected

      Shopping data on daily necessities, etc.

      Way of collection

      Receipt and Barcode Scanning

    • Implementation confirmed by multiple foreign and Japanese consumer goods manufacturers

      Development Update

    • Currently approaching primarily Japanese and Vietnamese consumer goods manufacturers

      Supermarket, Mini-mart Convenience Store, Pharmaceutical



      Grocery Store, Wet Market, Food Stall, Street Vendor Stall





      FMCG

      Hotel, Restaurant, Café, Milk Tea, Bakery



      Shopee, Tiktok Shop, Lazada, Tiki, Grab, Be, etc.



      Restaurant

      Pharmaceutical



      Electronics

  • Customized dashboards for existing clients

  • Preparing the product master to enable the expansion of product categories

Meeting strong demand for consumer panels and driving early adoption

Fashion & Lifestyle Entertainment

Launch of the Consumer Panel (i-Panel) in Vietnam

11



‌In the consumer goods manufacturers that are clients of INTAGE, business needs related to medical care, health, and beauty are expanding. By co-creating solutions that leverage the medical domain assets and expertise held by INTAGE Healthcare -such as data utilization and analytics- we can better meet the broad range of consumer needs that these manufacturers aim to address.

Consumer Profiles as Business Targets

Development of New Products and Services



Repurposing and Leveraging Existing Technologies

and Ingredients

Development of Products

Purchase Behavior of 70,000 Consumers

Plamed Doctor Monitor

Insights on medical settings, diseases, and patients

  • Pre-patient population

    • Disease prevention

Business Needs

Health

and Services Requiring Specialized Evidence and Expertise

Market trends based on sales data from 6,000 stores nationwide

Understand the symptoms and diseases from the perspective of healthcare consumers and patients

Utilizing disease-specific treatment insights for physician targeting

Research Themes and Needs

  • Development of apps that support healthy lifestyles

  • Understanding the pre-patient population for developing functional foods

  • Actual conditions of skin troubles

  • Realities of health, beauty, lifestyle-related diseases, and exercise therapy

  • Understanding on-site conditions in clinical and rehabilitation settings

  • Usage status of medical devices

  • Desire to utilize survey results from physicians

Medical

Beauty

INTAGE ×

INTAGE Healthcare



consumer goods manufacturers (clients of INTAGE)

Enabling proposals based on a comprehensive understanding of consumers

Value Creation through Group Co-Creation

- Expanding Cross-Segment Proposals -

12



‌Forecasts Capital Policy

‌Based on the performance through the second quarter and the outlook for the business environment going forward, the full-year earnings forecast remains unchanged. Each segment will continue efforts to generate new projects for the third quarter, which is the peak season for their core and growth businesses.

(Millions of yen)

6 months ended

Dec. 31, 2025

(Ⓐ)

Forecasts for the FY June 30, 2026

(Ⓑ)

Progress

Ⓑ - Ⓐ

(Reference) FY25/6 Second-Half Results

Full Year

Net sales

31,688

70,000

45.3%

38,312

33,544

Operating profit

2,363

5,600

42.2%

3,237

2,460

Ordinary profit

2,381

5,500

43.3%

3,119

2,387

Profit attributable to owners of parent

1,220

3,200

38.1%

1,980

1,488

Marketing Support (Consumer Goods & Services)

Net sales

21,790

49,100

44.4%

27,310

23,653

Operating profit

630

2,700

23.3%

2,070

1,208

Marketing Support (Healthcare)

Net sales

6,474

13,200

49.0%

6,726

5,823

Operating profit

1,547

2,400

64.4%

853

947

Business Intelligence

Net sales

3,423

7,700

44.5%

4,277

4,068

Operating profit

185

500

37.0%

315

305

The above forecast has been prepared based on information that is currently available to the Company and is subject to high levels of uncertainty. Actual results may differ from the forecast.

Forecasts for the Fiscal Year Ending June 30, 2026

14



‌Marketing Support (Consumer Goods & Services)

  • The core panel surveys remains solid. Custom research continues to struggle in some industries, but we expect year-on-year growth. We will focus on securing projects during the peak third quarter. Although the operating companies other than INTAGE and the overseas subsidiaries are facing difficult conditions, each is advancing measures to address their respective challenges.

  • In growth areas in collaboration with NTT DOCOMO, performance in the first half exceeded the previous year but fell short of the plan. We will continue to strengthen initiatives, including expanding the pipeline for d-Mileage projects, promoting data utilization consulting, and enhancing our CX management capabilities.

  • Operating profit improved significantly in the first half. We will continue rigorous project selection and price increases during the busy season.

Marketing Support (Healthcare)

  • The research businesses of INTAGE Healthcare and INTAGE Real World remain strong. We will continue to enhance our planning and proposal capabilities and strive to achieve our targets.

  • We will focus on creating value for client companies through new services, as well as strengthening the digital promotion capabilities of KYOWA KIKAKU. As a synergy with DOCOMO, we will place particular emphasis on the healthcare promotion domain.

Business Intelligence

  • The segment initially forecast a year-on-year decline in both revenue and profit for the full year, due to the recoil from the large-scale projects at Build System. which had contributed significantly to revenue and profit growth in FY2024. INTAGE TECHNOSPHERE expects both revenue and profit to remain at roughly the same level as the previous year.

  • Aiming for growth as a technology-driven company, we are currently investing in the development of industry-wide common solutions.

Business Environment for Each Segment and Outlook for Second half of FY2025

15



Expansion of business/increase in market expectations

‌Attaching importance to capital efficiency, allocate total final profit to "shareholder return" and "growth investment"

Precondition: Ratings BBB+

01

Shareholder return:

50% or more

(Target the year ending June 30, 2026)

02

Growth investment

  • Expense-related Investment

    (business investment, R&D, etc.)

  • Asset-related investment (tangible and intangible assets, M&A, etc.)

Long-term corporate value enhancement

ROE

12%-

  • Dividends

  • Acquisition of treasury shares

Profit

  • Depreciation equivalent

  • Borrowing (when needed)

Operating profit

Capital Policy

16



‌Dividend Policy 17

Based on our basic policy on profit distribution, for the fiscal year ending June 30, 2026, the increase in dividend will continue, with a dividend of 48 yen, an increase of 3 yen.

EPS

(earnings per share) (yen)

Dividend per share (yen)

Dividend payout ratio (consolidated) (%)

ROE

(return on equity) (%)

2Q

Year-end

Total

Year ended June 30, 2022

86.31

-

38.00

38.00

44.0

11.3

Year ended June 30, 2023

91.21

-

42.00

42.00

46.0

11.4

As of June 30, 2024

64.47

-

43.00

43.00

66.7

7.8

As of June 30, 2025

91.83

22.50

22.50

45.00

49.0

10.7

Year ending June 30, 2026

(Planned)

83.80

24.00

24.00

48.00

57.3

9.4

Basic Policy on Profit Distribution

Our basic policy is to distribute profits based on consolidated business performance, which is the result of Group management, while maintaining a balance between dividends and investment for growth. The Company aims to achieve a consolidated dividend payout ratio of 50% and ROE (return on equity) of 12% for the final fiscal year ending June 30, 2026. In addition, the Company will take flexible action regarding the acquisition of treasury shares in order to improve capital efficiency.

The Company's basic policy is to pay dividends from its surplus twice a year, an interim dividend and a year-end dividend.



  • ‌For FY2026/6, operating profit is expected to increase significantly (from 4.24 billion yen to 5.6 billion yen). However, profit attributable to owners of parent is expected to decrease due to a reactionary decrease from gains on sale of the CRO business recorded in FY2025/6, resulting in an expected ROE of 9.4%.

  • From FY2027/6 onward, we aim to achieve ROE of around 12% through continuous profit growth.

Recognition of Current Status

The Future

2.50

Trends in ROE and PBR

15.00%

2.00

1.50

10.00%

1.00

0.50

5.00%

0.00

2018.3 2019.3 2020.6 2021.6 2022.6 2023.6 2024.6 2025.6 2026.6

資本コ スト

Cost of Capital

PBR ROE

0.00%

©INTAGE GROUP

ROE Trends and Cost of Capital

18

  • We recognize that the cost of shareholders' equity has been in the 5%-8% range (we conservatively use 8.0% as our cost of capital for internal use)

  • For FY2025/6, ROE was 10.7% and PBR was 2.0x, an improvement from the previous fiscal year. This level is comparable to the period excluding FY2020/6, which was affected by the COVID-19 pandemic, and FY2024/6, which saw a temporary increase in expenses related to the parallel operation of the old and new SCI systems, and the capital and business alliance with DOCOMO. ROE has returned to a level exceeding the cost of capital (approx. 10-13%) and PBR has returned to a level of 1.2-2.0x.





‌appendix

‌Commenced deliberation on group reorganization as part of organizational restructuring aimed at building an optimal structure to realize the Group Vision 2030.

Background and Rationale

To realize our Vision 2030, we determined that fundamental organizational reforms are necessary to expand into new growth domains beyond our traditional business areas.

Accordingly, we aim to eliminate barriers between business segments and transition to a structure that maximizes profitability through the optimal allocation of management resources.

  1. Purpose of the Integration

    • Develop an organizational infrastructure that will enable the Company to realize new business value

    • Solve customer issues through company-wide value creation

  1. Integration Schedule(Planned)

    • Early August 2026 :Resolution to approve proposed organizational structure

    • July 1, 2027 :Start of new organization operation

The integration scheme and organizational structure will be announced once finalized.

  1. Method of Integration

    • Examine the optimal structure of the Group, focusing on the integration of the three core segment companies*.

    • Prior to the Group reorganization, INTAGE Real World Inc., a wholly owned subsidiary of INTAGE Healthcare Inc., will be merged into INTAGE Healthcare Inc. effective July 1, 2026.

*INTAGE Inc., INTAGE Healthcare Inc., and INTAGE TECHNOSPHERE Inc.

Regarding the Disclosure on February 5

Commencement of Deliberation on Group Reorganization Focusing on Integration of Consolidated Subsidiaries

21



‌2 years have now passed since the launch of the distribution data integration and analysis service POS-is®. POS-is is being increasingly adopted by mainly consumer goods manufacturers.

Number of service adopters (including tentative introduction)

15

8

10

Optimizes sales and manufacturing activities by automatically integrating POS data that differs by retailer and combining it with INTAGE's panel data and shipping data

POS

data

Site providing POS for each company/business

* No external provision of data is required as entire solution from

integrated platform to dashboard is built within customer environment.

Transaction data

Shipment and delivery data

INTAGE

master data

Demand forecasting

Inventory control

Promotional

investment management

Distribution management

INTAGE

market data

POS analysis

Formatted data

Formatting

and processing program

KPI management

BI tools Sales applications

Data integration platform

Customer-owned data



24/12 25/6 25/12

Data integration

Update

Acceleration of Industry Standardization

Through the full automation of analysis, not only has "productivity reform" been achieved, but its value as a "data-driven business transformation engine" - one that enables the standardization and advancement of proposals - has also been recognized, leading to growing adoption among top-tier companies in the industry.

Enhancement of Provided Value

In addition to conventional analysis, we are developing new features for implementation next fiscal year, such as inventory optimization and promotional ROI visualization, which enable improvements in cash flow and maximization of profits.

Distribution Data PF The Growing POS-is® Service Integrating POS Data and Optimization Sales and Manufacturing Activities

22



‌Data utilization support in the healthcare domain is performing strongly 23

The adoption of Cross Fact, the integrated medical database provided by INTAGE Real World Inc., which holds three types of medical receipt (reimbursement claim) data, continues to perform strongly. By leveraging a wide range of fact-based data, we provide solution-driven proposals tailored to the needs of pharmaceutical companies, thereby promoting more effective data utilization.



Fact Data

dispensing claim receipts

Social insurance claim receipts

NDB※1

Data from the claims review and payment organizations

Data from insurance-covered pharmacies (outpatient prescriptions)

Others

pharmaceutical master data

DPC data※2

Data from medical institutions

Integrated Medical Database

Cross Fact

High-Speed Processing / Scaled Estimation

Solution

Patient-Derived Sales

Dynamic Market Share

Regional mesh data (area analysis)

History Chart (Patient Journey)

Regimen analysis

/ line analysis※3

and more

※1 National Data Base:A database used for surveys and analyses related to the formulation, implementation, and evaluation of medical cost optimization plans, storing and organizing data such as medical claim information and specific health checkup/specific health guidance information. ※2 Diagnosis Procedure Combination ※3 Analysis of drug combinations and treatment sequences.

©INTAGE GROUP



‌Accelerating Alliances to Become a Data + Technology Company

Aim: Create touchpoints with advanced technologies and services

Overview: Established with SBI Investment Co., Ltd. Total amount generated: 5 billion yen Operation period: October 2016 through March 2027

Features of investment:

The fund is operated based on the fund features (sourcing, business evaluation, monitoring, etc.) provided by SBI Investment Co., Ltd. By having INTAGE Group employees actively participate throughout the sourcing phase, they gain expertise in business evaluation, network with venture companies and serve as a channel for collecting information. This helps improve the effectiveness of alliance activities.

Investment results: 2.85 billion yen has been invested in 28 companies (as of December 2025)

Investing companies (as of December 2025)

Marketing

Research and Innovation Co., Ltd.

Payke, Inc. XICA CO.,LTD.

BitStar Inc.

Healthcare

Dr. JOY Co., Ltd.

Ubie Inc.

FiNC Technologies Inc. CureApp, Inc.

Platform

EverySense, Inc. Tamer Inc. ambr, Inc.

AI

Cross Compass Ltd. Godot Inc.

Life

every, Inc. Alice. style, Inc.

Image and video

technologies

EmbodyMe, Inc.

* Invested in three other companies (company names not disclosed)

Exit results: IPO: four companies, M&A: five companies



Investment examples

  • Operates the shopping information registration app "CODE"

  • Invested in November 2017, and made a subsidiary of INTAGE, Inc. in May 2021

  • We are utilizing the company's proprietary technology for reading receipts in SCI renewal

  • Develops medical DX services such as the symptom search engine "Ubie" used by over

    12 million people per month

  • Invested in November 2020

  • We are considering collaborations with our healthcare segment



About INTAGE Open Innovation Fund

24



‌Summary of Consolidated Balance Sheets

24/12

25/12

Increase/ Decrease

Current assets

30,533

30,438

-94

Non-current assets

16,389

16,729

+340

Total assets

46,922

47,168

+245

Current liabilities

12,567

12,330

-236

Non-current liabilities

1,034

1,018

-15

Total liabilities

13,601

13,349

-252

Total net assets

33,321

33,818

+497

Total assets

46,922

47,168

+245



Summary of Consolidated Statements of Cash Flows

Cash flows from operating activities

24/6

25/12

482

-2,034

Cash flows from investing activities

1,400

-523

Cash flows from financing activities

-1,776

-1,056

Effect of exchange rate change on cash and cash equivalents

-20

46

Net increase (decrease) in cash and cash equivalents

86

-3,567

Cash and cash equivalents at beginning of period

11,940

16,492

Cash and cash equivalents at end of period

12,026

12,924

Net cash provided by (used in) operating activities

Due to the seasonality of revenue recognition, accounts receivable collection becomes concentrated in the second half of the year, resulting in negative operating cash flow.



Net cash provided by (used in) investment activities

Investment cash flow turned to a net outflow, mainly due to increased investment in business-related software development at ITG and ITSP.



Net cash provided by (used in) financing activities

As a result of the interim dividend system introduced in the previous fiscal year, dividend payments decreased year on year, resulting in a net outflow in financing cash flow.

Summary of Consolidated Balance Sheets and Consolidated Statements of Cash Flows

(Millions of yen)

25



‌(Millions of yen)

17,609

18,918

16,969

17,327

16,432

15,057

14,306

14,361

14,930

14,625

20,000

Trend in net sales

(Millions of yen)

Trend in operating profit

18,000

16,000

3,000

2,486

1,778

1,791

1,594

1,331

572

198

-19

-27

187

2,500

14,000

2,000

12,000

1,500

1,000

10,000

500

8,000

1Q(7~9) 2Q(10~12) 3Q(1~3) 4Q(4~6)

0

-500

1Q(7~9) 2Q(10~12) 3Q(1~3) 4Q(4~6)

Year ended June 30, 2024

Year ended June 30, 2025

Year ending June 30, 2026

Trend in quarterly results

26





Quarterly net sales breakdown by product

27



‌3Q(Cumulative)

3Q(Noncumulative)

4Q(Cumulative)

4Q(Noncumulative)

(Millions of yen)

Year ended June Year ended June Year ending June

30, 2024 30, 2025 30, 2026

Year ended June Year ended June Year ending June

30, 2024 30, 2025 30, 2026

Year ended June Year ended June Year ending June

30, 2024 30, 2025 30, 2026

Year ended June Year ended June Year ending June

30, 2024 30, 2025 30, 2026

C G

S

Panel Surveys

11,920

11,779

4,096

3,991

16,088

16,043

4,168

4,264

CR

10,006

11,393

3,819

4,213

12,471

14,213

2,465

2,820

Co

1,885

2,673

708

878

2,435

3,435

550

762

Overseas

4,260

4,393

1,630

1,652

5,374

5,710

1,114

1,317

Other

3,512

5,125

2,091

2,941

4,805

5,940

1,293

815

H C

Panel Surveys

2,756

2,832

915

958

3,712

3,811

956

979

CR

3,480

3,960

984

1,245

4,688

4,969

1,208

1,009

CRO

1,979

324

583

0

2,577

324

598

0

Promotion

2,110

2,017

640

635

2,780

2,751

670

734

Other

430

465

153

153

577

575

147

110

B I

SI

2,536

2,040

720

744

3,187

2,593

651

553

BPO and maintenance

1,637

1,774

581

719

2,087

2,418

451

644

DX

1,831

2,166

688

790

2,492

2,784

661

618

Quarterly net sales breakdown by product

28